As news surfaced that the Bush administration is
considering appointing Dr. David Hager, a Lexington OB-GYN, to a high-profile
FDA committee on reproductive drugs, several major news sources sprang into
"search and destroy" mode in efforts to discredit him as too "controversial."
Time led the charge in a story riddled with
fact errors, saying, among other things, that Hager was a volunteer at UK
Medical School, (he is actually a salaried professor, and directs UK’s OB-GYN
residency program at Lexington’s Central Baptist Hospital) and that he’s
"scantily credentialed." (Hager has written several books—including medical
school texts—as well as over 40 journal articles. He has also served as
assistant surgeon at the Centers for Disease Control, and has served on
enough medical boards and received enough honors to make your head spin.
New York Times columnist Maureen Dowd, in her
scathing review of Hager, asked whether we were "so worried about medieval
villains abroad that we no longer worry about medievalism at home."
Newsweek’s Anna Quindlen added her shrill voice to the
chorus by saying Hager "doesn’t approve of prescribing contraceptives to
adult women." (Apparently Quindlen believes one good lie deserves another.
The Time article reported that Hager refused to prescribe
contraceptives to unmarried women. Both statements are untrue.)
Quindlen added later in her "Last Word" commentary that "it would be a
pitiful nation that would let those fringe zealots run things for the rest of
us."
It makes one wonder if Hager studied obstetrics at the
Butcher Holler one-room schoolhouse, or got his medical license from Voodoo
priests in Haiti. But in reality, his transgression is far worse—he’s an
outspoken Christian and a pro-life advocate. Such "sins" are often enough to
black ball anyone from a powerful Washington position and call into question
a resume to rival Einstein’s.
Dowd and others are engaging in what The Family Research
Council calls "religious profiling" by writing slanted articles that
insinuate that adherence to the Christian faith is an abject disqualifier for
scientific thought. But somewhere in the warping of the words, Dowd
referenced Hager’s public criticism of RU-486—and that’s where the
rubber finally met the road. Hager’s appointment to the FDA Committee on
Reproductive Drugs in Women might well bring attention to the health risks of
one of the pro-choice lobby’s "scantily credentialed" sacred cows—the
abortion pill.
Hager and several groups have filed a Citizen’s Petition
with the FDA asking that RU-486, also called Mifeprex, be removed from the
market until further study can confirm its safety. Hager maintains that
although he is pro-life, he and others filed the petition because of a large
body of evidence concerning health risks to women and children. (See related
article, pg. 3)
Consequences of Mifeprex can be dire, and yes, women in
this country have died from what can go terribly wrong. Even news articles
sympathetic to abortion-on-demand quote women who say of the drug, "I woke up
in a pool of blood." Despite the Clinton administration’s rush to get it
here, and its uncharacteristically easy approval by the FDA, it hasn’t been
the boon to the abortion industry that some predicted it would be. One reason
is that it can take up to two weeks of cramping and bleeding before the
process is complete, and the woman has to dispose of the "product of
conception" herself—something that may be a challenge for those weak of
stomach and vulnerable of conscience.
Pro-choice and pro-life doctors alike say surgical
abortion is more effective than the abortion pill, so why is the pro-choice
lobby so sold on it? The bottom line may be—you guessed it—the bottom line.
"Yes, it’s more profitable," said Diane Maracich, who manages the chemical
abortion program for Long Beach-based Family Planning Associates.
Profitable or not, Mifeprex is bad medicine, and Hager is
being a good doctor by showing what it’s capable of doing to women and
children. If there’s a "controversy" it’s that Hager went after Mifeprex, so
the pro-choice lobby went after him. But controversy or not, if Hager is
appointed to the committee, his meticulous research and his medical expertise
will likely shine the stark light of truth into the darker political recesses
of the FDA. It’s a big decision, and in this case, it may well be a matter of
life and death.